The COVID-19 pandemic represents a significant and urgent threat to global health. The grant opportunity aims to increase clinical trial activity in Australia by supporting new high quality research into COVID-19, an area of unmet medical need.
The Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) COVID-19 grant opportunity is now open for applications in Sapphire.
Unmet medical need arises where members of the Australian community are living with a serious (debilitating or life-threatening) health condition where there are no satisfactory options for prevention, diagnosis, early detection or treatment of the condition that would support improved health outcomes. In addition, an unmet medical need could arise where there has been little or no progress in the development of tools or therapies to address the condition.
The objective of this Grant Opportunity is to utilise clinical trials to investigate effective mechanisms for the prevention or treatment of COVID-19 or its symptoms. Applications must propose a clinical trial that addresses a gap in current research and/or knowledge in with a specific focus on COVID-19.
The intended outcome of this research is to deliver high quality evidence of strategies for the prevention or treatment of COVID-19 or its symptoms that can be translated into policy or practice.
This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health.
Further information on the Medical Research Future Fund (MRFF) is available from the Department of Health’s MRFF website.